Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Groove Botanicals (GRVE) EBITDA Margin (2016 - 2017)

Groove Botanicals' EBITDA Margin history spans 8 years, with the latest figure at 2687.66% for Q1 2017.

  • For Q1 2017, EBITDA Margin rose 5358887.0% year-over-year to 2687.66%; the TTM value through Mar 2017 reached 3866.46%, up 911363.0%, while the annual FY2024 figure was 3949.35%, 313911.0% up from the prior year.
  • EBITDA Margin for Q1 2017 was 2687.66% at Groove Botanicals, down from 3752.1% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 3752.1% in Q4 2016 and bottomed at 56276.53% in Q1 2016.
  • The 5-year median for EBITDA Margin is 411.33% (2014), against an average of 4520.48%.
  • The largest annual shift saw EBITDA Margin tumbled -3862743bps in 2016 before it skyrocketed 5358887bps in 2017.
  • A 5-year view of EBITDA Margin shows it stood at 354.77% in 2013, then soared by 49bps to 181.6% in 2014, then crashed by -213bps to 568.47% in 2015, then skyrocketed by 760bps to 3752.1% in 2016, then plummeted by -172bps to 2687.66% in 2017.
  • Per Business Quant, the three most recent readings for GRVE's EBITDA Margin are 2687.66% (Q1 2017), 3752.1% (Q4 2016), and 977.03% (Q3 2016).